|
1
|
Kayahara M, Nagakawa T, Ueno K, Ohta T,
Takeda T and Miyazaki I: An evaluation of radical resection for
pancreatic cancer based on the mode of recurrence as determined by
autopsy and diagnostic imaging. Cancer. 72:2118–2123. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sener SF, Fremgen A, Menck HR and
Winchester DP: Pancreatic cancer: a report of treatment and
survival trends for 100,313 patients diagnosed from 1985–1995,
using the National Cancer Database. J Am Coll Surg. 189:1–7.
1999.PubMed/NCBI
|
|
3
|
Sperti C, Pasquali C, Piccoli A and
Pedrazzoli S: Recurrence after resection for ductal adenocarcinoma
of the pancreas. World J Surg. 21:195–200. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Han SS, Jang JY, Kim SW, Kim WH, Lee KU
and Park YH: Analysis of long-term survivors after surgical
resection for pancreatic cancer. Pancreas. 32:271–275. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sohn TA, Yeo CJ, Cameron JL, et al:
Resected adenocarcinoma of the pancreas-616 patients: results,
outcomes, and prognostic indicators. J Gastrointest Surg.
4:567–579. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Howard TJ, Krug JE, Yu J, et al: A
margin-negative R0 resection accomplished with minimal
postoperative complications is the surgeon’s contribution to
long-term survival in pancreatic cancer. J Gastrointest Surg.
10:1338–1346. 2006.PubMed/NCBI
|
|
7
|
Raut CP, Tseng JF, Sun CC, et al: Impact
of resection status on pattern of failure and survival after
pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg.
246:52–60. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Winter JM, Cameron JL, Campbell KA, et al:
1423 pancreaticoduodenectomies for pancreatic cancer: A
single-institution experience. J Gastrointest Surg. 10:1199–1211.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Riall TS, Cameron JL, Lillemoe KD, et al:
Pancreaticoduodenectomy with or without distal gastrectomy and
extended retroperitoneal lymphadenectomy for periampullary
adenocarcinoma - part 3: update on 5-year survival. J Gastrointest
Surg. 9:1191–1206. 2005.
|
|
10
|
Farnell MB, Pearson RK, Sarr MG, et al;
Pancreas Cancer Working Group. A prospective randomized trial
comparing standard pancreatoduodenectomy with pancreatoduodenectomy
with extended lymphadenectomy in resectable pancreatic head
adenocarcinoma. Surgery. 138:618–630. 2005. View Article : Google Scholar
|
|
11
|
Pedrazzoli S, DiCarlo V, Dionigi R, et al:
Standard versus extended lymphadenectomy associated with
pancreatoduodenectomy in the surgical treatment of adenocarcinoma
of the head of the pancreas: a multicenter, prospective, randomized
study. Lymphadenectomy Study Group. Ann Surg. 228:508–517. 1998.
View Article : Google Scholar
|
|
12
|
Iqbal N, Lovegrove RE, Tilney HS, et al: A
comparison of pancreaticoduodenectomy with extended
pancreaticoduodenectomy: a meta-analysis of 1909 patients. Eur J
Surg Oncol. 35:79–86. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kurahara H, Takao S, Maemura K, et al:
Impact of lymph node micrometastasis in patients with pancreatic
head cancer. World J Surg. 31:483–492. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Geer RJ and Brennan MF: Prognostic
indicators for survival after resection of pancreatic
adenocarcinoma. Am J Surg. 165:68–73. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Trede M, Schwall G and Saeger HD: Survival
after pancreatoduodenectomy. 118 consecutive resections without an
operative mortality. Ann Surg. 211:447–458. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yeo CJ, Cameron JL, Lillemoe KD, et al:
Pancreaticoduodenectomy for cancer of the head of the pancreas. 201
patients. Ann Surg. 221:721–733. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sobin LH and Wittekind C: TNM
Classification of Malignant Tumours (UICC). 5th edition. John Wiley
& Sons; New York, NY: 1997
|
|
18
|
Japanese Pancreas Society. Classification
of Pancreatic Carcinoma. 1st English edition. Kanehara huppan;
Tokyo, Japan: 1996
|
|
19
|
Yoshiaki M, Kenichiro U, Takeshi S, et al:
Prognostic impact of para-aortic lymph node metastasis in
pancreatic ductal adenocarcinoma. World J Surg. 34:1900–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Doi R, Kami K, Ito D, et al: Prognostic
implication of para-aortic lymph node metastasis in resectable
pancreatic cancer. World J Surg. 31:147–154. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sakai M, Nakao A, Kaneko T, et al:
Para-aortic lymph node metastasis in carcinoma of the head of the
pancreas. Surgery. 137:606–611. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Andersen HB, Baden H, Brahe NE and
Burcharth F: Pancreaticoduodenectomy for periampullary
adenocarcinoma. J Am Coll Surg. 179:545–552. 1994.PubMed/NCBI
|
|
23
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC cancer Staging Manual. 7th edition.
Springer; New York, NY: 2010
|
|
24
|
Ishikawa O, Ohigashi H, Sasaki Y, et al:
Practical grouping of positive lymph nodes in pancreatic head
cancer treated by an extended pancreatectomy. Surgery. 121:244–249.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakao A, Harada A, Nonami T, et al: Lymph
node metastases in carcinoma of the head of the pancreas region. Br
J Surg. 82:399–402. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yoshida T, Aramaki M, Matsumoto T, Morii
Y, Sasaki A and Kitano S: The pattern of lymphatic spread in
carcinoma of the distal bile duct. Int Surg. 83:124–127.
1998.PubMed/NCBI
|
|
27
|
Yoshida T, Matsumoto T, Sasaki A, Shibata
K, Aramaki M and Kitano S: Outcome of paraaortic node-positive
pancreatic head and bile duct adenocarcinoma. Am J Surg.
187:736–740. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shimada K, Sakamoto Y, Sano T and Kosuge
T: The role of paraaortic lymph node involvement on early
recurrence and survival after macroscopic curative resection with
extended lymphadenectomy for pancreatic carcinoma. J Am Coll Surg.
203:345–352. 2006. View Article : Google Scholar
|
|
29
|
Kayahara M, Nagakawa T, Ohta T, et al:
Analysis of paraaortic lymph node involvement in pancreatic
carcinoma: a significant indication for surgery? Cancer.
85:583–590. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamada S, Nakao A, Fujii T, et al:
Pancreatic cancer with paraaortic lymph node metastasis: a
contraindication for radical surgery? Pancreas. 38:e13–e17. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Moertel CG, Frytak S, Hahn RG, et al:
Therapy of locally unresectable pancreatic carcinoma: a randomized
comparison of high dose (6000 rads) radiation alone, moderate dose
radiation (4000 rads + 5-fluorouracil), and high dose radiation +
5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer.
48:1705–1710. 1981.PubMed/NCBI
|
|
32
|
McGuckin MA, Cummings MC, Walsh MD, Hohn
BG, Bennett IC and Wright RG: Occult axillary node metastases in
breast cancer: their detection and prognostic significance. Br J
Cancer. 73:88–95. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jiao X, Eslami A, Ioffe O, et al:
Immunohistochemistry analysis of micrometastasis in pretreatment
lymph nodes from patients with esophageal cancer. Ann Thorac Surg.
76:996–1000. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tanabe T, Nishimaki T, Watanabe H, et al:
Immunohistochemically detected micrometastasis in lymph nodes from
superficial esophageal squamous cell carcinoma. J Surg Oncol.
82:153–159. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ishigami S, Natsugoe S, Tokuda K, et al:
Clinical impact of micrometastasis of the lymph node in gastric
cancer. Am Surg. 69:573–577. 2003.PubMed/NCBI
|
|
36
|
Bilchik AJ, Hoon DS, Saha S, et al:
Prognostic impact of micrometastases in colon cancer: interim
results of a prospective multicenter trial. Ann Surg. 246:568–577.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bosch RC: Interview with Dr. Ramón Colomer
Bosch, President of the Spanish Society of Medical Oncology (SEOM)
by Enrique Garcia Jorda. Clin Transl Oncol. 10:310–312. 2008.
|
